Tag Archives: AMGN

Best Tech Stocks To Own For 2018

401(k) Savers May Have to Fund Trumps Corporate Tax Cut

Texas Judge Denies Emergency Request to Block DOL Fiduciary Rule

Did Warren Overreach in Blasting Annuity Sales Perks?

Advisors’ bonuses are not maintaining the same pace as industry profit growth, according to the New York State Comptroller’s office.

The latest results of the yearly survey find that....More>>>

Wednesdays Vital Data: Alibaba Group Holding Ltd (BABA), Amgen Inc. (AMGN) and Advanced Micro Dev

U.S. stock futures are plunging this morning. Another key exit from the Donald Trump White House has set investors on edge, as Gary Cohn, the head of President Trump’s National Economic Council, resigned. Cohn was considered a moderating voice in the White House, and opposed Trump’s tariff proposal.

As a result, Dow Jones Industrial Average futures have plummeted 1.02%, S&P....More>>>

Hot Biotech Stocks To Invest In 2018

William Patalon III

I learned a lot of things during the three decades I’ve spent watching, chronicling and digging deep into the machinations of the world’s public companies.

And one of the key lessons I learned was also one of the most powerful when it comes to making money.

The lesson: When troubled companies make serious upgrades in their executive ranks,....More>>>

Best Biotech Stocks To Watch Right Now

Tesla (NSDQ:TSLA)announced that it has entered into an agreement to acquire Grohmann Engineering, a German engineering company, which will become Tesla Grohmann Automation and pave the way for the Tesla Advanced Automation Germany headquarters, with other locations to follow. The company plans to add over 1,000 advanced engineering and skilled technician jobs in Germany over the next two years.


Hot Biotech Stocks To Own Right Now

Stocks edged higher today despite Donald Trump trashing the health care sector in his press conference today.

Getty Images

The S&P 500 rose 0.3% to 2,275.32 today, while the Dow Jones Industrial Average gained 98.75 points, or 0.5%, to 19,954.28. The Nasdaq Composite advanced 0.2% to5,563.65–and hit its fifth consecutive high–despite the fact that biotech stocks tumbled....More>>>

Top 10 Biotech Stocks To Invest In Right Now

Allergan (NYSE:AGN) is one of the many biotech stocks that has been beaten down in the last one and a half year. In this article I will indicate 4 reasons why I think the company and the stock can perform well in the future.

Reason #1: Diversified sources of revenue and rich pipeline

One of the characteristics that I like in Allergan is its rich portfolio of drugs. As we can see....More>>>

Week In Review: Nearly $2 Billion Late-December Week For China Pharma Deals

Nanjing Legend Biotech received a $350 million upfront payment from Janssen Biotech, which will form a global partnership with Legend for its highly effective CAR-T candidate. In June, Legend, which was not previously well known, surprised the annual ASCO meeting with stunningly positive results from an early trial of the CAR-T molecule in patients with multiple myeloma. In addition to the $350....More>>>

Hot Biotech Stocks To Own For 2018

bluebird bio, (NASDAQ:BLUE) is one of the oncology immunotherapy stocks I mentioned recently as worth a good look, (article titled ‘Immunotherapy Over Reaction’, a basic primer to the immunotherapy subsector and its ETF). BLUE is also a recent Cramer pick. Immunotherapy stocks have been hit hard over the summer but BLUE is a relatively highly valued genetic specialist, with some interesting....More>>>

Top 5 Biotech Stocks To Watch For 2018

What happened

Puma Biotechnology (NASDAQ:PBYI) ended the day down 13.8% after Roche (NASDAQOTH:RHHBY) reported that its rival breast cancer drug, Perjeta, had passed its phase 3 trial, dubbed “Aphinity.”

Image source: Getty Images.

So what

In Roche’s trial, patients either took Perjeta and Herceptin with chemotherapy or just Herceptin with chemotherapy,....More>>>

Top 10 Biotech Stocks To Invest In 2018

One of the smaller details of Trumpcare, the redacted version of Obamacare, is the elimination of a tax imposed on manufacturers of medical devices. While the fate of pre-existing conditions has been hogging the spotlight in recent days, this particular tax and its future could have an impact on companies like Ventripoint Diagnostics (OTCMKTS: VPTDF TSE:VPT), and other small cap biotech....More>>>